Transgenic and knockout analyses of the role of TNF in immune regulation and disease pathogenesis

Journal of Inflammation

Volumn 47, Issue 1-2, 1995, Pages 27-38

  Douni, Eleni ^a   Akassoglou, Katerina ^a   Alexopoulou, Lena ^a   Georgopoulos, Spiros ^a   Haralambous, Sylva ^a   Hill, Sally ^a   Kassiotis, George ^a   Kontoyiannis, Dimitris ^a   Pasparakis, Manolis ^a   Plows, David ^a   Probert, Lesley ^a   Kollias, George ^a  

^a HELLENIC PASTEUR INSTITUTE   (Greece)

Author keywords

anti bacterial host defence; arthritis CNS inflammation; autoimmunity; B cell follicles; contact hypersensitivity; germinal centres; LPS toxicity; TNF receptors; transmembrane TNF

Indexed keywords

TUMOR NECROSIS FACTOR;

ANIMAL MODEL; AUTOIMMUNITY; CONFERENCE PAPER; GENE EXPRESSION; GENE STRUCTURE; IMMUNE RESPONSE; IMMUNOREGULATION; INFECTION; MOUSE; NONHUMAN; PATHOGENESIS; PRIORITY JOURNAL;

ADJUVANTS, IMMUNOLOGIC; ANIMALS; COMMUNICABLE DISEASES; HUMANS; IMMUNE SYSTEM; IMMUNE SYSTEM DISEASES; MICE; MICE, KNOCKOUT; MICE, TRANSGENIC; TUMOR NECROSIS FACTOR-ALPHA;

EID: 0029554533     PISSN: 10787852     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Conference Paper

References (64)

1. Ferez C, Albert I, DeFay K, Zachariades N, Gooding L, Kriegler M: A non-secretable cell surface mutant of tumour necrosis factor (TNF-a) kills by cell to cell contact. Cell 63:251-258, 1990.
2. Vandenbeele P, Declercq W, Beyaert R, Fiers W: Two tumour necrosis factor receptors: Structure and function. Trends Cell Biol 5:392-399, 1995.
3. Tartaglia LA, Weber RF, Figari IS, Reynolds C, Palladino MA Jr, Goeddel DV: The two different receptors for tumor necrosis factor mediate distinct cellular responses. Proc Natl Acad Sei U S A 88:92929296, 1991.
4. Gehr G, Gentz R, Brockhaus M, Loetscher H, Lesslauer W: Both tumor necrosis factor receptor mediate proliferative signals in human mononuclear cell activation. J Immunol 149:911-917, 1992.
5. Ranges GE, Zlotnik A, Espevik T, Dinarello CA, Cerami A, Palladino MA Jr: Tumor necrosis factor o/cachectin is a growth factor for thymocytes. J ExpMed 167:14721478, 1988.
6. Tartaglia LA, Goeddel DV, Reynolds C, Figari IS, Weber RF, Fendly BM, Palladino MA Jr: Stimulation of human T-cell proliferation by specific activation of the 75-kDa tumor necrosis factor receptor. J Immunol 151:46374641, 1993.
7. Thoma B, Grell M, Pfizenmaier K, Scheurich P: Identification of a 60-kD tumor necrosis factor (TNF) receptor as the major signal transducing component in TNF responses. J Exp Med 172:1019-1023, 1990.
8. Tartaglia LA, Rothe M, Hu YF, Goeddel DV: Tumor necrosis factor' s cytotoxic activity is signaled by the p55 TNF-a receptor. Cell 73:213-216, 1993.
9. Tartaglia LA, Ayres TM, Wong GH, Goeddel DV: A novel domain within the 55kd TNF-a receptor signals cell death. Cell 74:845-853, 1993.
10. Grell M, Zimmermann G, Hulser D, Pfizenmaier K, Scheurich P: TNF receptors TR60 and TR80 can mediate apoptosis via induction of distinct signal pathways. J Immunol 153:1963-1972, 1994.
11. Zheng L, Fisher G, Miller RE, Peschon J, Lynch DH, Lenardo MJ: Induction of apoptosis in mature T cells by tumour necrosis factor. Nature 377:348-351, 1995.
12. Grell M, Douni E, Wajant H, Lohden M, Clauss M, Maxeiner B, Georgopoulos S, Lesslauer W, Kollias G, Pfizenmaier K, Scheurich P: The transmembrane form of tumor necrosis factor is the prime activating ligand of the 80 kDa tumor necrosis factor receptor. Cell 83:793-802, 1995.
13. Keffer J, Probert L, Cazlaris H, Georgopoulos S, Kaslaris E, Kioussis D, Kollias G: Transgenic mice expressing human tumour necrosis factor: A predictive genetic model of arthritis. EMBO J 10:4025-4031, 1991.
14. Probert L, Keffer J, Corbella P, Cazlaris H, Patsavoudi E, Stephens S, Kaslaris E, Kioussis D, Kollias G: Wasting, ischaemia and lymphoidabnormalities in mice expressing T cell-targeted human tumor necrosis factor transgenes. J Immunol 151:1894-1906, 1993.
15. Probert L, Akassoglou K, Pasparakis M, Kontogeorgos G, Kollias G: Spontaneous inflammatory demyelinating disease in transgenic mice showing CNS-specific expression of tumor necrosis factor a. Proc Natl Acad Sei U S A 92:11294-11298, 1995.
16. Akassoglou K, Probert L, Kontogeorgos G, Kollias G: A role for astrocyte-specific transmembrane TNF in thé triggering of inflammation, demyelination and neuronal degeneration in the CNS of transgenic mice. J Immunol, in press.
17. Pasparakis M, Alexopoulou L, Episkopou V, Kollias G: Immune and inflammatory responses in TNFa knockout mice: A critical requirement for TNFa in primary Bcell follicle and germinal centre formation and in the maturation of the humoral immune response. J Exp Med Vol. 184, 1996, in press.
18. Pfeffer K, Matsuyama T, Kunding TM, Wakeham A, Kishihara K, Shahinian A, Wiegmann K, Ohashi PS, Kronke M, Mak TW: Mice deficient for the 55 kD tumour necrosis factor receptor are resistant to endotoxic shock, yet succumb to L. monocytogenes infection. Cell 73:457-467, 1993.
19. Rothe J, Lesslauer W, Lotscher H, Lang Y, Koebel P, Kontgen F, Aithage A, Zinkernagel R, Steinmetz M, Bluethmann H: Mice lacking the tumour necrosis factor receptor 1 are resistant to TNF-mediated toxicity but highly susceptible to infection by Listeria monocytogenes. Nature 364:798-802, 1993.
20. Erickson SL, J de Sauvage F, Kikly K, Carver-Moore K, Pitts-Meek S, Gillett N, Sheehan KC-F, Schreiber RD, Goeddel DV, Moore MW: Decreased sensitivity to tumour-necrosis factor but normal T-cell development in TNF receptor-2-deficient mice. Nature 372:560-563, 1994.
21. van den Berg WB, Joosten LAB, Helsen M, van de Loo FAJ: Amelioration of established murine collagen-induced arthritis with anti-IL-1 treatment. Clin Exp Immunol 95:237-243, 1994.
22. Probert L, Plows D, Kontogeorgos G, Kollias G: The type I interleukin-1 receptor acts in series with tumor necrosis factor (TNF-oc) to induce arthritis in TNF-α transgenic mice. Eur J Immunol 25:1794-1797, 1995.
23. Zvaifler NJ, Firestein GS: Pannus and pannocytes, alternative models of joint destruction in rheumatoid arthritis. Arthritis Rheum 37:783-789, 1994.
24. Geiler T, Kriegsmann J, Keyszer GM, Gay RE, Gay S: A new model for rheumatoid arthritis generated by engraftment of rheumatoid synovial tissue and normal human cartilage into SCID mice. Arthritis Rheum 37:1664-1671, 1994.
25. Lewis M, Tartaglia LA, Lee A, Bennett GL, Rice GC, Wong GHW, Chen EY, Goeddel DV: Cloning and expression of cDNAs for two distinct murine tumor necrosis factor receptors demonstrate one receptor is species specific. Proc Natl Acad Sei U S A 88:2830-2834, 1991.
26. Shaw G, Kamen R: A conserved UA sequence from the 3'untranslated region of GM-CSF mRNA mediates selective mRNA degradation. Cell 46:659-667, 1986.
27. Zubiaga A, Belasco J, Greenberg M: The nonamer UUAUUUAUU is the key AU-rich sequence motif that mediates mRNA degradation. Mol Cell Biol 15:2219-2230, 1995.
28. Kruys V. Wathelet M, Huez G: Identification of translational inhibitory element (TIE) in the 3'untranslated region of the human interferon- mRNA. Gene 72:191200, 1988.
29. Kruys V, Beutler B, Huez G: Translational control mediated by UA-rich sequences. Enzyme 44:193-202,1990.
30. Caput D, Beutler B, Hartog K, Thayer R, Brown-Shimer S, Cerami A: Identification of a common nucleotide sequence in the 3'untranslated region of mRNA molecules specifying inflammatory mediators. Proc Natl Acad Sei U S A 83:1670-1674, 1986.
31. Kruys V, Kemmer K, Shakhov A, Jongeneel V, Beutler B: Constitutive activity of the tumor necrosis factor is canceled by the 3'untranslated region in nonmacrophage cell lines; a trans-dominant factor overcomes this suppressive effect. Proc Natl Acad Sei U S A 89:673-677, 1992.
32. Han J, Brown T, Beutler B: Endotoxin responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med 171:465475, 1990.
33. Beutler B, Brown T: Polymorphism of the mouse TNFa locus: Sequence studies of the 3'untranslated region and first intron. Gene 129:279-283, 1993.
34. Jacob C, Beerman-Tashaman N: Disruption in the AU motif of the mouse TNF-α 3′DTR correlates with reduced TNF production by macrophages in vitro. Nucleic Acids Res 21:2761-2766, 1993.
35. Lee JC, Laydon JT, McDonnell PC, Gallagher TF, Kumar S, Green D, NcNulty D, Blumental MJ, Heys RJ, Landvatter SW, Strickler JE, McLaughlin MM, a Siemens l, Fischer S, Livi GP, White JR, Adams JL, Young PR: Identification and characterization of a novel protein kinase involved in the regulation of inflammatory cytokine biosynthesis. Nature 372: 739-746, 1994.
36. Prichett W, Hand A, Sheilds J, Dunnington D: Mechanisms of action of bicyclic imidazoles defines a translational regulatory pathway of tumor necrosis factor alpha. J Inflamm 45:97-105, 1995.
37. Feldmann M, Brennan FM, Maini RN: Role of cytokines in rheumatoid arthritis. Ann Rev Immunol 14:397-440, 1996.
38. Hofman FM, Hinton DR, Johnson K, Merrill JE: Tumor necrosis factor identified in multiple sclerosis brain. J Exp Med 170:607- 612, 1989.
39. Selmaj K, Raine CS, Cannella B, Brosnan CF: Identification of lymphotoxin and tumor necrosis factor in multiple sclerosis lesions. J Clin Invest 87:949-954, 1991.
40. Tyor WR, Glass JD, Griffin JW, Backer PS, McArthur JC, Bezman L, Griffin DE: Cytokine expression in the brain during the acquired immunodeficiency syndrome. Ann Neurol 31:349-360, 1992.
41. Grau GE, Piguet PF, Vassalli P, Lambert PH: Tumor necrosis factor and other cytokines in cerebral malaria: Experimental and clinical data. Immunol Rev 189:49-70, 1989.
42. Selmaj K, Raine CS: Tumor necrosis factor mediates myelin and oligodendrocyte damage in vitro. Ann Neurol 23:339-346, 1988.
43. Selmaj K, Raine CS, Farooq M, Norton WT, Brosnan CF: Cytokine cytotoxicity against oligodendrocytes. Apoptosis induced by lymphotoxin. J Immunol 147: 1522-1529, 1991.
44. Sharief MK, Hentges R: Association between tumor necrosis factor and disease progression in patient with multiple sclerosis. N Engl J Med 325:467-472, 1991.
45. Georgopoulos S, Plows D, Kollias G: Transmembrane TNF is sufficient to induce localized tissue toxicity and chronic inflammatory arthritis in transgenic mice. J Inflamm 46:86-97, 1996.
46. Cumberbatch M, Kimber I: Tumour necrosis factoralpha is required for accumulation of dendritic cells in draining lymph nodes and for optimal contact sensitisation. Immunol 84:31-35, 1995.
47. Piguet PF, Grau GE, Hauser C, Vassalli P: Tumour necrosis factor is a critical mediator in hapten induced irritant and contact hypersensitivity reactions. J Exp Med 173:673-679, 1991.
48. Bromberg JS, Chavin KD, Kunkel SL: Anti-tumour necrosis factor antibodies suppress cell-mediated immunity in vivo. J Immunol 148:3412-3417, 1992.
49. Kurimoto I, Streilein JW: c/s-urocanic supression of contact hypersensitivity induction is mediated via tumour necrosis factor-a. J Immunol 148:3072-3078, 1992.
50. Kondo S, Wang B, Fujisawa H, Shivji GM, Echtenacher B, Mak TW, Sauder DN: Effect of gene-targeted mutation in TNF receptor (p55) on contact hypersensitivity and ultraviolet B-induced immunosuppression. J Immunol 155:3801-3805, 1995.
51. De Togni P, Goellner J, Ruddle NH, Streeter PR, Pick A, Mariathasan S, Smith SC, Carlson R, Shornick LP, Strauss-Schoenberger J, Rüssel JH, Karr R, Chaplin D: Abnormal development of peripheral lymphoid organs in mice deficient in lymphotoxin. Science 264:703-707, 1994.
52. Matsumoto M, Mariathasan S, Nahm MH, Baranyay F, Peschon J, Chaplin D: Role of lymphotoxin and the type I TNF receptor in the formation of germinal centres. Science 271:1289-1291, 1996.
53. Le Hir M, Bluethmann H, Kosco-Vilbois MH, Muller M, di Padova F, Moore M, Ryffel B, Eugster HP: Differentiation of follicular dentritic cells and full antibody responses require tumour necrosis factor receptor-1 signalling. J Exp Med 183:2367-2372, 1996.
54. Neumann B, Machleidt T, Lifka A, Pfeffer K, Vestweber D, Mak TW, Holtzmann B, Kronke M: Crucial role of 55-kilodalton TNF receptor in TNF-induced adhesion molecule expression and leukocyte organ infiltration. J Immunol 156:1587-1593, 1996.
55. Picker LJ, Butcher EC: Physiological and molecular mechanisms of lymphocyte homing. Ann Rev Immunol 10:561-591, 1992.
56. Medeiros LJ, Picker LJ, Abel EA, Hu CH, Hoppe RT, Warnke RA, Wood GS: Cutaneous lymphoid hyperplasia. J Am Acad Dermatol 21:929-942, 1990.
57. Duijvestijn AM, Horst E, Pals ST, Rouse BN, Steere AC, Picker LJ, Meijer CJLM, Butcher EC: High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am J Pathol 130:147-155, 1988.
58. Freemont AJ: A possible route for lymphocyte migration into diseased tissues. J Clin Pathol 36:161-166, 1983.
59. Randen I, Mellbye OJ, Forre 0, Natvig JB: The identification of germinal centres and follicular dendritic cell networks in rheumatoid synovial tissue. Scand J Immunol 41:481-486, 1995.
60. Schröder AE, Greiner A, Seyfert C, Berek C: Differentia-tion of B cells in the nonlymphoid tissue of the synovial membrane of patients with rheumatoid arthritis. Proc Natl Acad Sei U S A 93:221-225, 1996.
61. Leprince C, Cohen-Kaminsky S, Berrih-Aknin S, Vernetder Garabedian B, Treton D, Galanaud P, Richard Y: Thymic B cells from myasthenia gravis patients are activated B cells. J Immunol 145:2115-2122, 1990.
62. Mooij P, Wit HJD, Drexhage HA: An excess of dietary iodine accelerates the development of a thyroid-asso-dated lymphoid tissue in autoimmune prone BB rats. Clin Immunol Immunopath 69:189-198, 1993.
63. Kratz A, Campos-Neto A, Hanson MS, Ruddle N: Chronic inflammation caused by lymphotoxin is lymphoid neogenesis. J Exp Med 183:1461-1472, 1996.
64. Penn AS, Jaretzki AMI, Wolff M, Chang HW, Tennyson V: Thymic abnormalities: Antigen or antibody? Response to thymectomy in myasthenia gravis. Ann NY Acad Sei 377:789-791, 1981.